GEN highlights six AI-based drug discoverers worthy of note based on pipeline or platform progress, and in one instance, a ...

Cancer cell death via necroptosis can be accompanied by the release of IL-1a, which can restrict anticancer immunity and ...

Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...

Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

The locus coeruleus was found to facilitate the transition between NREM and REM sleep states while maintaining an unconscious ...

Bitter taste receptor has hidden intracellular pocket that enables activation via simultaneous extracellular/intracellular ...

Martin A. Makary, MD, of Johns Hopkins University, a critic of vaccination schedules and COVID-19 measures promulgated by ...

Researchers hope findings will lead to new class of drugs for many different diseases for which proteolethargy is a common denominator.

Using high-resolution cryo-electron microscopy researchers uncovered unprecedented detail of gyrase’s action on DNA.

Diabetes drug development gets an advance in study that shows Inceptor binds excess insulin within the beta cell and directs it towards degradation.

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.